Krailo M - Search Results

1

Feasibility Study of a Novel Experimental Induction Protocol Combining B43-PAP (Anti-CD19) Immunotoxin With Standard Induction Chemotherapy in Children and Adolescents With Relapsed B-Lineage ALL: A Report From the Children's Oncology Group.

Meany HJ, Seibel NL, Krailo M, Villaluna D, Chen Z, Gaynon P, Neglia JP, Park JR, Hutchinson R, Sato JK, Wells RJ, Woods WG, Reaman G. Meany HJ, et al. Among authors: krailo m. J Immunother. 2015 Sep;38(7):299-305. doi: 10.1097/CJI.0000000000000088. J Immunother. 2015. PMID: 26261894 Free PMC article. Clinical Trial.

2

Lack of significant activity of 2'-deoxycoformycin alone or in combination with adenine arabinoside in relapsed childhood acute lymphoblastic leukemia. A randomized phase II trial from the Childrens Cancer Study Group.

Miser JS, Roloff J, Blatt J, Reaman GH, Krailo MD, Hammond GD. Miser JS, et al. Among authors: krailo md. Am J Clin Oncol. 1992 Dec;15(6):490-3. doi: 10.1097/00000421-199212000-00005. Am J Clin Oncol. 1992. PMID: 1449110 Clinical Trial.

3

Pharmacology of fludarabine phosphate after a phase I/II trial by a loading bolus and continuous infusion in pediatric patients.

Avramis VI, Champagne J, Sato J, Krailo M, Ettinger LJ, Poplack DG, Finkelstein J, Reaman G, Hammond GD, Holcenberg JS. Avramis VI, et al. Among authors: krailo m. Cancer Res. 1990 Nov 15;50(22):7226-31. Cancer Res. 1990. PMID: 1699658 Clinical Trial.

4

Efficacy and toxicity of 12 courses of ABVD chemotherapy followed by low-dose regional radiation in advanced Hodgkin's disease in children: a report from the Children's Cancer Study Group.

Fryer CJ, Hutchinson RJ, Krailo M, Collins RD, Constine LS, Hays DM, Heller RM, Davis PC, Nachman J, O'Brien RT, et al. Fryer CJ, et al. Among authors: krailo m. J Clin Oncol. 1990 Dec;8(12):1971-80. doi: 10.1200/JCO.1990.8.12.1971. J Clin Oncol. 1990. PMID: 1700080 Clinical Trial.

5

Determination of the maximum tolerated dose of idarubicin when used in a combination chemotherapy program of reinduction of childhood ALL at first marrow relapse and a preliminary assessment of toxicity compared to that of daunorubicin: a report from the Childrens Cancer Study Group.

Feig SA, Krailo MD, Harris RE, Baum E, Holcenberg JS, Kaizer H, Steinherz L, Pendergrass TW, Saunders EF, Warkentin PL, et al. Feig SA, et al. Among authors: krailo md. Med Pediatr Oncol. 1992;20(2):124-9. doi: 10.1002/mpo.2950200207. Med Pediatr Oncol. 1992. PMID: 1734217 Clinical Trial.

6

Pharmacology and phase I trial of high-dose oral leucovorin plus 5-fluorouracil in children with refractory cancer: a report from the Children's Cancer Study Group.

Patel R, Newman EM, Villacorte DG, Sato JK, Reaman GH, Finklestein JZ, Krailo MD, Hammond GD, Holcenberg JS. Patel R, et al. Among authors: krailo md. Cancer Res. 1991 Sep 15;51(18):4871-5. Cancer Res. 1991. PMID: 1893377 Clinical Trial.

7

Carboplatin in childhood brain tumors. A Children's Cancer Study Group Phase II trial.

Gaynon PS, Ettinger LJ, Baum ES, Siegel SE, Krailo MD, Hammond GD. Gaynon PS, et al. Among authors: krailo md. Cancer. 1990 Dec 15;66(12):2465-9. doi: 10.1002/1097-0142(19901215)66:12<2465::aid-cncr2820661204>3.0.co;2-n. Cancer. 1990. PMID: 2249186 Clinical Trial.

8

A phase II study of carboplatin in children with recurrent or progressive solid tumors. A report from the Childrens Cancer Group.

Ettinger LJ, Gaynon PS, Krailo MD, Ru N, Baum ES, Siegel SE, Hammond GD. Ettinger LJ, et al. Among authors: krailo md. Cancer. 1994 Feb 15;73(4):1297-301. doi: 10.1002/1097-0142(19940215)73:4<1297::aid-cncr2820730427>3.0.co;2-#. Cancer. 1994. PMID: 8313334 Clinical Trial.

9

A phase I study of carboplatin in children with acute leukemia in bone marrow relapse. A report from the Childrens Cancer Group.

Ettinger LJ, Krailo MD, Gaynon PS, Hammond GD. Ettinger LJ, et al. Among authors: krailo md. Cancer. 1993 Aug 1;72(3):917-22. doi: 10.1002/1097-0142(19930801)72:3<917::aid-cncr2820720342>3.0.co;2-q. Cancer. 1993. PMID: 8334645 Clinical Trial.

10

American Cancer Society Workshop on Adolescents and Young Adults with Cancer. Workgroup #4: Clinical research implications.

Hammond GD, Nixon DW, Nachman JB, Murphy SB, Ho RC, Smith MA, Reaman G, Bernstein L, Krailo M, Young JL. Hammond GD, et al. Among authors: krailo m. Cancer. 1993 Apr 1;71(7):2423. doi: 10.1002/1097-0142(19930401)71:7<2423::aid-cncr2820710740>3.0.co;2-#. Cancer. 1993. PMID: 8453565 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

357 results

Search Page

Filters